Saturday 17 October 2026 Export TLIS’s income statement to Excel — free account

Talis Biomedical Corporation

Talis Biomedical Corporation’s revenue for fiscal 2023 (year ended December 2023) was $2.1 million, down 55.7% from fiscal 2022. Operating cash flow growth for three consecutive years.

2.84 0.00 0.00%

Follow TLIS

Alert me

Market cap: $46.3M
P/E: 0.0×
Fwd P/E: −0.3×
Dividend yield: —
F-score: 4/9
Altman Z: −9.10
Beneish M: −4.89
Dividend safety: n/a

Overview Business Profile Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '24	Mar '24	Dec '23	Sep '23	Older periods
P/E ratio Full definition →	—	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	—	15.66	6.85	4.84
P/FCF ratio Full definition →	—	0.00	0.00	0.00
P/Operating CF Full definition →	—	(2.41)	(1.29)	(0.95)
P/B ratio Full definition →	—	0.27	0.21	0.13
Price to Tangible BV Full definition →	—	0.27	0.21	0.13
EV/Sales Full definition →	—	(55.46)	(29.11)	(35.23)
EV/EBITDA Full definition →	—	0.90	0.94	1.01
EV/Operating CF Full definition →	—	1.27	1.17	1.40
EV/FCF Full definition →	—	1.26	1.16	1.38
Quick Ratio Full definition →	7.30	7.43	8.75	10.41
Current Ratio Full definition →	7.76	7.51	8.86	10.60
Net Debt/EBITDA Full definition →	6.31	5.08	5.39	5.25
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.00	0.01	0.02	0.01
Operating CF/Net income Full definition →	1.28	0.49	0.84	0.71
Capex/Depreciation Full definition →	1.00	0.11	0.44	(0.32)
Research and Development Expense of Revenue Full definition →	0.00%	3,469.86%	4,123.59%	5,930.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	15,960.27%	3,385.64%	6,287.86%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	0.00%	823.29%	523.08%	765.71%
Graham Net Nets Full definition →	—	2.93	3.57	6.01
Graham Number Full definition →	—	0.00	0.00	0.00
Earnings Yield Full definition →	—	(369.76%)	(425.06%)	(715.38%)
Free Cash Flow Yield Full definition →	—	(281.73%)	(367.67%)	(527.64%)
Revenue per Share Full definition →	0.00	0.04	0.11	0.08
Operating CF per Share Full definition →	(6.22)	(3.53)	(6.25)	(6.13)
Capex per Share Full definition →	0.05	0.02	0.05	(0.04)
Free Cash Flow per Share Full definition →	(6.17)	(3.51)	(6.20)	(6.16)
Cash per Share Full definition →	32.85	38.60	42.22	48.37
Shareholders Equity per Share Full definition →	26.68	31.11	38.03	44.83
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	26.68	31.11	38.03	44.83
Free Cash Flow Full definition →	(11.25)	(6.40)	(11.26)	(11.21)
Working Capital Full definition →	55.41	61.70	68.91	81.08
Capital Expenditures Full definition →	0.08	0.03	0.09	(0.07)
Net Current Asset Value Full definition →	39.53	45.36	52.13	63.86
EV/EBIT Full definition →	—	0.89	0.93	0.96
Capex to Sales Full definition →	0.00	(0.41)	(0.48)	0.50
Price to Operating Income Full definition →	—	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	—	0.07	0.18	0.22
Average Payables Full definition →	3.14	3.75	2.55	3.40
Average Assets Full definition →	97.89	107.77	131.98	150.66
Average Common Equity Full definition →	72.39	83.40	97.92	116.97

Show all line items

Columns are period end dates

Stockrow Weekly